GLAXOSMITHKLINE PHARMACEUTICALS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,000 INR | +1.42% |
|
-4.33% | +5.61% |
| May. 09 | Drugmaker Abbott India posts Q4 profit rise on higher sales | RE |
| Apr. 25 | GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 684B | ||||||
| 568B | ||||||
| 361B | ||||||
| 329B | ||||||
| 284B |
